Fuda Cancer Hospital
Chemotherapy for breast cancer in China typically costs from $14,800 to $31,000. The total price depends on the drug regimen, cancer stage, and facility tier. In the US, similar treatments cost around $37,500 on average. Patients can find savings of approximately 39% in China. Typical costs cover medications, oncologist consultations, and basic diagnostic monitoring during the treatment cycles.
Bookimed Expert Insight: Choosing JCI-accredited centers like Fuda Cancer Hospital provides access to unique specialist combinations. This facility has treated over 30,000 international patients using advanced minimally invasive techniques. While standard chemo is available, many patients opt for Cryosurgery or NanoKnife therapies. These specialized procedures often serve as effective alternatives for late-stage cases where traditional chemotherapy alone is insufficient.
| China | Turkey | Austria | |
| Chemotherapy for breast cancer | from $14,800 | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for breast cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for breast cancer journey.
Day 1: Arrival
Day 2: Pre-Operation
Day 3: Chemotherapy
Day 4: Post-Operation
Day 5: Departure
Week 1-4: Rehabilitation
Week 8: Final Result
Please note that the process may vary based on individual health condition and response to the treatment.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
Chemotherapy for breast cancer is a systemic treatment using drugs to destroy cancer cells in the body.